Compare EXPE & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPE | STE |
|---|---|---|
| Founded | 1996 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5B | 25.9B |
| IPO Year | 1999 | 1992 |
| Metric | EXPE | STE |
|---|---|---|
| Price | $263.00 | $263.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 9 |
| Target Price | $249.12 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 2.7M | 653.3K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | 0.61% | ★ 0.96% |
| EPS Growth | 35.97 | ★ 59.39 |
| EPS | ★ 10.37 | 6.97 |
| Revenue | ★ $14,370,000,000.00 | $5,702,415,000.00 |
| Revenue This Year | $8.74 | $9.24 |
| Revenue Next Year | $7.19 | $6.30 |
| P/E Ratio | ★ $25.39 | $37.76 |
| Revenue Growth | ★ 7.29 | 7.08 |
| 52 Week Low | $130.01 | $200.98 |
| 52 Week High | $279.61 | $268.60 |
| Indicator | EXPE | STE |
|---|---|---|
| Relative Strength Index (RSI) | 61.48 | 59.06 |
| Support Level | $257.63 | $256.68 |
| Resistance Level | $266.00 | $268.60 |
| Average True Range (ATR) | 8.11 | 4.64 |
| MACD | 0.09 | -0.69 |
| Stochastic Oscillator | 91.25 | 65.59 |
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.